$TXO

Raymond James Lowers TXO Partners (TXO) Target but Backs High Dividend Yield

Raymond James cut its TXO Partners (NYSE:TXO) price target to $20 from $22 while keeping a Strong Buy rating, citing a weaker oil price outlook. The note said TXO’s high dividend yield and low base production decline support the recommendation. TXO plans to sell most assets via a $200M deal, expecting ~$100M proceeds and Q2 2026 close.

Original reporting
Published Jul 1, 2026, 6:30 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 1, 2026, 10:09 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Raymond James Lowers TXO Partners (TXO) Target but Backs High Dividend Yield — source image
Decision brief

The 30-second read

$TXONeutralLow
01

Why it matters

The actionable change is an analyst price-target reduction due to weaker oil outlook, partially offset by a reiterated Strong Buy and emphasis on high dividend yield and production decline profile.

02

Market read

For traders, the note mainly affects sentiment/valuation expectations; the larger fundamental catalyst is the planned asset divestiture close in Q2 2026, which is not newly disclosed here.

03

What to watch

The article highlights a divestiture and expected cash use, but does not provide new timing/terms beyond the already-expected Q2 2026 close; traders may need confirmation of closing and proceeds impact on leverage/coverage.

Relevance 5/10Novelty 5/10Timing: after-hours/early premarket analyst note (June 24) referenced on July 1

Background

TXO is an MLP focused on conventional oil, gas, and NGLs; it plans to receive proceeds from a JV asset sale and redeploy part toward a White Rock Energy-related payment.

Company-level read

Ticker impact

$TXONeutralMedium confidence
Context

Raymond James lowered its price target on TXO to $20 from $22 citing a weaker oil outlook, while reiterating Strong Buy.

Expected impact

Likely limited near-term downside bias; dividend yield narrative may support the stock despite the lower target.

Evidence & confidence

The only new decision is the analyst price-target reduction tied to oil outlook; the article does not add new TXO operational or deal details beyond previously stated divestiture expectations.

Market effects

Reinforces sensitivity of high-yield MLPs to oil-price assumptions and dividend sustainability narratives.

None specific beyond North American upstream exposure.

Oil-price outlook is globally relevant, but the article’s catalyst is analyst-driven rather than a macro print.

Counterpoint

The dividend yield (11.51% cited) and low base production decline rate could outweigh oil-price weakness in the near term for income-focused flows.

Key entities

  • TXO Partners, L.P.

    Master limited partnership; Raymond James cut its price target while reiterating Strong Buy and citing weaker oil outlook.

  • Raymond James

    Issued the June 24 research note lowering TXO target to $20 from $22.

  • Cross Timbers Energy

    JV selling nearly all oil and gas assets to private buyers for $200 million, expected to close in Q2 2026.

Related articles

$IBBMedAI 8/10

Biotech ETF Rises 23% as Drug Milestones Span Trials to Approval

The iShares Biotechnology ETF (IBB) rose 23.1% through Oct. 23, driven by drug milestones. Merck and Moderna reported positive Phase 3 trial data for intismeran autogene. Roche's Enspryng gained FDA approval for thyroid eye disease. Eli Lilly plans to submit a weight-loss drug for FDA review in early 2027. IBB's expense ratio is 0.44%, while SPDR S&P Biotech ETF (XBI) has a 0.35% expense ratio.

$CRWDMed

CrowdStrike’s CEO Says a Wave of Cyber Attacks Are Coming

CrowdStrike's CEO warned of impending cyberattacks due to PHP vulnerabilities, leading to an 8.25% stock price increase. Palo Alto Networks and other cybersecurity firms also saw gains. The flaws could impact millions of servers, with AI-powered attacks on the rise. CrowdStrike's professional services revenue reached $71 million last quarter, while Palo Alto's firewalls offer rapid protection against new threats.

$METAMedAI 8/10

Why Meta's spending sent stocks lower during a volatile market week

Meta Platforms Inc. reported revenue beat and raised 2026 capital spending to $135B, but its stock fell 7% due to cost concerns. Nasdaq 100 dropped 2.9%, led by a 6.7% decline in chip stocks. CoreWeave Inc. bonds yield near 15%, shares slid 11% this week. SpaceX posted first profit since IPO, revenue up 161% to $14.6B. GM, Ford, and Stellantis stocks fell despite GM's revenue and earnings beat.